retatrutide clinical trials retatrutide parkinson's trial Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed Reta clinical trial data &
Description
J Clin Invest 1998
or randomized.ab
Common Side Effects Nausea Vomiting Diarrhea Constipation Reduced appetite Headache Fatigue Retatrutides side-effect profile is a reassuring sign of safety
Each serving delivers a combination of nutrients in capsule form, designed for easy daily use
However, when combined with GLP-1 receptor activation, this hyperglycemic effect becomes balanced
